{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:47:53Z","timestamp":1773092873306,"version":"3.50.1"},"publisher-location":"Singapore","reference-count":82,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811072291","type":"print"},{"value":"9789811072307","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-981-10-7230-7_7","type":"book-chapter","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T10:29:29Z","timestamp":1528799369000},"page":"123-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Vaccine Development for Varicella-Zoster Virus"],"prefix":"10.1007","author":[{"given":"Tomohiko","family":"Sadaoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMoa066092","volume":"357","author":"IJ Amanna","year":"2007","unstructured":"Amanna IJ, Carlson NE, Slifka MK (2007) Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 357:1903\u20131915. https:\/\/doi.org\/10.1056\/NEJMoa066092","journal-title":"N Engl J Med"},{"key":"7_CR2","first-page":"2015","volume-title":"Fields virology","author":"AM Arvin","year":"2013","unstructured":"Arvin AM, Gilden D (2013) Varicella-zoster virus. In: Knipe DM, Howley PM (eds) Fields virology, 6th edn. Wolters Kluwer Health, Philadelphia, pp 2015\u20132057","edition":"6"},{"key":"7_CR3","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.4049\/jimmunol.137.4.1346","volume":"137","author":"AM Arvin","year":"1986","unstructured":"Arvin AM, Kinney-Thomas E, Shriver K et al (1986) Immunity to varicella-zoster viral glycoproteins, gp I (gp 90\/58) and gp III (gp 118), and to a nonglycosylated protein, p 170. J Immunol 137:1346\u20131351","journal-title":"J Immunol"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/82_2009_2","volume":"342","author":"Y Azarkh","year":"2010","unstructured":"Azarkh Y, Gilden DH, Cohrs RJ (2010) Molecular characterization of varicella zoster virus in latently infected human ganglia: physical state and abundance of VZV DNA, quantitation of viral transcripts and detection of VZV-specific proteins. Curr Top Microbiol Immunol 342:229\u2013241. https:\/\/doi.org\/10.1007\/82_2009_2","journal-title":"Curr Top Microbiol Immunol"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","volume":"20","author":"M Brisson","year":"2002","unstructured":"Brisson M, Gay NJ, Edmunds WJ, Andrews NJ (2002) Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 20:2500\u20132507","journal-title":"Vaccine"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/infdis\/156.3.430","volume":"156","author":"PA Brunell","year":"1987","unstructured":"Brunell PA, Novelli VM, Keller PM, Ellis RW (1987) Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response. J Infect Dis 156:430\u2013435","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"7_CR7","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1086\/522161","volume":"197","author":"SS Chaves","year":"2008","unstructured":"Chaves SS, Haber P, Walton K et al (2008a) Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995\u20132005. J Infect Dis 197(Suppl 2):S170\u2013S177. https:\/\/doi.org\/10.1086\/522161","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"7_CR8","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1086\/522150","volume":"197","author":"SS Chaves","year":"2008","unstructured":"Chaves SS, Zhang J, Civen R et al (2008b) Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997\u20132005. J Infect Dis 197(Suppl 2):S127\u2013S131. https:\/\/doi.org\/10.1086\/522150","journal-title":"J Infect Dis"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.vaccine.2015.09.073","volume":"34","author":"R Chlibek","year":"2016","unstructured":"Chlibek R, Pauksens K, Rombo L et al (2016) Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults. Vaccine 34:863\u2013868. https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.073","journal-title":"Vaccine"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1097\/INF.0b013e3181a90b16","volume":"28","author":"R Civen","year":"2009","unstructured":"Civen R, Chaves SS, Jumaan A et al (2009) The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 28:954\u2013959. https:\/\/doi.org\/10.1097\/INF.0b013e3181a90b16","journal-title":"Pediatr Infect Dis J"},{"key":"7_CR11","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1128\/JVI.69.12.8151-8154.1995","volume":"69","author":"P Clarke","year":"1995","unstructured":"Clarke P, Beer T, Cohrs RJ, Gilden DH (1995) Configuration of latent varicella-zoster virus DNA. J Virol 69:8151\u20138154","journal-title":"J Virol"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","volume":"33","author":"RL Coffman","year":"2010","unstructured":"Coffman RL, Sher A, Seder RA (2010) Vaccine adjuvants: putting innate immunity to work. Immunity 33:492\u2013503. https:\/\/doi.org\/10.1016\/j.immuni.2010.10.002","journal-title":"Immunity"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/82_2010_11","volume":"342","author":"JI Cohen","year":"2010","unstructured":"Cohen JI (2010) Rodent models of varicella-zoster virus neurotropism. Curr Top Microbiol Immunol 342:277\u2013289. https:\/\/doi.org\/10.1007\/82_2010_11","journal-title":"Curr Top Microbiol Immunol"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13365-016-0480-1","volume":"23","author":"RJ Cohrs","year":"2016","unstructured":"Cohrs RJ, Badani H, Baird NL et al (2016) Induction of varicella zoster virus DNA replication in dissociated human trigeminal ganglia. J Neurovirol 23:1\u20136. https:\/\/doi.org\/10.1007\/s13365-016-0480-1","journal-title":"J Neurovirol"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham AL, Lal H, Kovac M et al (2016) Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med 375:1019\u20131032. https:\/\/doi.org\/10.1056\/NEJMoa1603800","journal-title":"N Engl J Med"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1016\/j.vaccine.2012.01.088","volume":"30","author":"N Dendouga","year":"2012","unstructured":"Dendouga N, Fochesato M, Lockman L et al (2012) Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice. Vaccine 30:3126\u20133135. https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.088","journal-title":"Vaccine"},{"key":"7_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027805","volume":"6","author":"DP Depledge","year":"2011","unstructured":"Depledge DP, Palser AL, Watson SJ et al (2011) Specific capture and whole-genome sequencing of viruses from clinical samples. PLoS One 6:e27805. https:\/\/doi.org\/10.1371\/journal.pone.0027805","journal-title":"PLoS One"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/molbev\/mst210","volume":"31","author":"DP Depledge","year":"2014","unstructured":"Depledge DP, Kundu S, Jensen NJ et al (2014) Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans. Mol Biol Evol 31:397\u2013409. https:\/\/doi.org\/10.1093\/molbev\/mst210","journal-title":"Mol Biol Evol"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1128\/JVI.00998-16","volume":"90","author":"DP Depledge","year":"2016","unstructured":"Depledge DP, Yamanishi K, Gomi Y et al (2016) Deep sequencing of distinct preparations of the live attenuated Varicella-Zoster Virus vaccine reveals a conserved Core of attenuating single-nucleotide polymorphisms. J Virol 90:8698\u20138704. https:\/\/doi.org\/10.1128\/JVI.00998-16","journal-title":"J Virol"},{"issue":"Suppl 2","key":"7_CR20","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1086\/522125","volume":"197","author":"SA Galea","year":"2008","unstructured":"Galea SA, Sweet A, Beninger P et al (2008) The safety profile of varicella vaccine: a 10-year review. J Infect Dis 197(Suppl 2):S165\u2013S169. https:\/\/doi.org\/10.1086\/522125","journal-title":"J Infect Dis"},{"key":"7_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.16","volume":"1","author":"AA Gershon","year":"2015","unstructured":"Gershon AA, Breuer J, Cohen JI et al (2015) Varicella zoster virus infection. Nat Rev Dis Primers 1:15016. https:\/\/doi.org\/10.1038\/nrdp.2015.16","journal-title":"Nat Rev Dis Primers"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/306478a0","volume":"306","author":"DH Gilden","year":"1983","unstructured":"Gilden DH, Vafai A, Shtram Y et al (1983) Varicella-zoster virus DNA in human sensory ganglia. Nature 306:478\u2013480","journal-title":"Nature"},{"key":"7_CR23","doi-asserted-by":"publisher","unstructured":"Gilden DH, Nagel M, Cohrs R et al (2015) Varicella Zoster Virus in the nervous system. F1000Res. https:\/\/doi.org\/10.12688\/f1000research.7153.1","DOI":"10.12688\/f1000research.7153.1"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/infdis\/jiw101","volume":"213","author":"DH Gilden","year":"2016","unstructured":"Gilden DH, White T, Boyer PJ et al (2016) Varicella Zoster Virus infection in granulomatous arteritis of the Aorta. J Infect Dis 213:1866\u20131871. https:\/\/doi.org\/10.1093\/infdis\/jiw101","journal-title":"J Infect Dis"},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/1096-9071(200008)61:4<497::AID-JMV13>3.0.CO;2-2","volume":"61","author":"Y Gomi","year":"2000","unstructured":"Gomi Y, Imagawa T, Takahashi M, Yamanishi K (2000) Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity. J Med Virol 61:497\u2013503","journal-title":"J Med Virol"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"11447","DOI":"10.1128\/JVI.76.22.11447-11459.2002","volume":"76","author":"Y Gomi","year":"2002","unstructured":"Gomi Y, Sunamachi H, Mori Y et al (2002) Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol 76:11447\u201311459","journal-title":"J Virol"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1016\/j.vaccine.2010.06.056","volume":"28","author":"N Goulleret","year":"2010","unstructured":"Goulleret N, Mauvisseau E, Essevaz-Roulet M et al (2010) Safety profile of live varicella virus vaccine (Oka\/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP). Vaccine 28:5878\u20135882. https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.056","journal-title":"Vaccine"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev.mi.44.100190.000423","volume":"44","author":"C Grose","year":"1990","unstructured":"Grose C (1990) Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking. Annu Rev Microbiol 44:59\u201380. https:\/\/doi.org\/10.1146\/annurev.mi.44.100190.000423","journal-title":"Annu Rev Microbiol"},{"key":"7_CR29","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","volume":"325","author":"I Hardy","year":"1991","unstructured":"Hardy I, Gershon AA, Steinberg SP, LaRussa P (1991) The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella vaccine collaborative study group. N Engl J Med 325:1545\u20131550. https:\/\/doi.org\/10.1056\/NEJM199111283252204","journal-title":"N Engl J Med"},{"key":"7_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jmv.1890300114","volume":"30","author":"DR Harper","year":"1990","unstructured":"Harper DR, Kangro HO, Heath RB (1990) Antibody responses in recipients of varicella vaccine assayed by immunoblotting. J Med Virol 30:61\u201367","journal-title":"J Med Virol"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1056\/NEJMoa013441","volume":"347","author":"A Hata","year":"2002","unstructured":"Hata A, Asanuma H, Rinki M et al (2002) Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 347:26\u201334. https:\/\/doi.org\/10.1056\/NEJMoa013441","journal-title":"N Engl J Med"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0140-6736(76)92397-7","volume":"2","author":"A Hattori","year":"1976","unstructured":"Hattori A, Ihara T, Iwasa T et al (1976) Use of live varicella vaccine in children with acute leukaemia or other malignancies. Lancet 2:210. https:\/\/doi.org\/10.1016\/S0140-6736(76)92397-7","journal-title":"Lancet"},{"key":"7_CR33","first-page":"9","volume":"58","author":"RE Hope-Simpson","year":"1965","unstructured":"Hope-Simpson RE (1965) The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58:9\u201320","journal-title":"Proc R Soc Med"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jcv.2016.10.022","volume":"85","author":"S Iwasaki","year":"2016","unstructured":"Iwasaki S, Motokura K, Honda Y et al (2016) Vaccine-strain herpes zoster found in the trigeminal nerve area in a healthy child: a case report. J Clin Virol 85:44\u201347. https:\/\/doi.org\/10.1016\/j.jcv.2016.10.022","journal-title":"J Clin Virol"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/S0264-410X(01)00486-8","volume":"20","author":"A Jacquet","year":"2002","unstructured":"Jacquet A, Haumont M, Massaer M et al (2002) Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation. Vaccine 20:1593\u20131602","journal-title":"Vaccine"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.virol.2016.06.017","volume":"496","author":"JS Jeon","year":"2016","unstructured":"Jeon JS, Won YH, Kim IK et al (2016) Analysis of single nucleotide polymorphism among Varicella-Zoster Virus and identification of vaccine-specific sites. Virology 496:277\u2013286. https:\/\/doi.org\/10.1016\/j.virol.2016.06.017","journal-title":"Virology"},{"key":"7_CR37","first-page":"99","volume":"27","author":"H Kamiya","year":"1984","unstructured":"Kamiya H, Kato T, Isaji M et al (1984) Immunization of acute leukemic children with a live varicella vaccine (Oka strain). Biken J 27:99\u2013102","journal-title":"Biken J"},{"key":"7_CR38","first-page":"29","volume":"25","author":"N Katsushima","year":"1982","unstructured":"Katsushima N, Yazaki N, Sakamoto M et al (1982) Application of a live varicella vaccine to hospitalized children and its follow-up study. Biken J 25:29\u201342","journal-title":"Biken J"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/cid\/ciw296","volume":"63","author":"K Kawai","year":"2016","unstructured":"Kawai K, Yawn BP, Wollan P, Harpaz R (2016) Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis 63:221\u2013226. https:\/\/doi.org\/10.1093\/cid\/ciw296","journal-title":"Clin Infect Dis"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"11311","DOI":"10.1128\/JVI.74.23.11311-11321.2000","volume":"74","author":"GW Kemble","year":"2000","unstructured":"Kemble GW, Annunziato PW, Lungu O et al (2000) Open reading frame S\/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells. J Virol 74:11311\u201311321","journal-title":"J Virol"},{"key":"7_CR41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1086\/600120","volume":"200","author":"KE Kester","year":"2009","unstructured":"Kester KE, Cummings JF, Ofori-Anyinam O et al (2009) Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S\/AS01B and RTS,S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J Infect Dis 200:337\u2013346. https:\/\/doi.org\/10.1086\/600120","journal-title":"J Infect Dis"},{"key":"7_CR42","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/1743-422X-8-547","volume":"8","author":"JI Kim","year":"2011","unstructured":"Kim JI, Jung GS, Kim YY et al (2011) Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax. Virol J 8:547. https:\/\/doi.org\/10.1186\/1743-422X-8-547","journal-title":"Virol J"},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.virol.2010.06.016","volume":"405","author":"T Koshizuka","year":"2010","unstructured":"Koshizuka T, Ota M, Yamanishi K, Mori Y (2010) Characterization of varicella-zoster virus-encoded ORF0 gene\u00a0\u2013 comparison of parental and vaccine strains. Virology 405:280\u2013288. https:\/\/doi.org\/10.1016\/j.virol.2010.06.016","journal-title":"Virology"},{"key":"7_CR44","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Chlibek R et al (2015) Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 372:2087\u20132096. https:\/\/doi.org\/10.1056\/NEJMoa1501184","journal-title":"N Engl J Med"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.1016\/j.vaccine.2010.08.035","volume":"28","author":"I Leroux-Roels","year":"2010","unstructured":"Leroux-Roels I, Koutsoukos M, Clement F et al (2010) Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems. Vaccine 28:7016\u20137024. https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.035","journal-title":"Vaccine"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/infdis\/jis497","volume":"206","author":"I Leroux-Roels","year":"2012","unstructured":"Leroux-Roels I, Leroux-Roels G, Clement F et al (2012) A phase 1\/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults. J Infect Dis 206:1280\u20131290. https:\/\/doi.org\/10.1093\/infdis\/jis497","journal-title":"J Infect Dis"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/INF.0000000000000821","volume":"34","author":"J Leung","year":"2015","unstructured":"Leung J, Lopez AS, Blostein J et\u00a0al (2015) Impact of the US two-dose Varicella vaccination program on the epidemiology of Varicella outbreaks: data from nine states, 2005\u20132012. Pediatr Infect Dis J 34:1105\u20131109. https:\/\/doi.org\/10.1097\/INF.0000000000000821","journal-title":"Pediatr Infect Dis J"},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1086\/379048","volume":"188","author":"MJ Levin","year":"2003","unstructured":"Levin MJ, Smith JG, Kaufhold RM et al (2003) Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 188:1336\u20131344. https:\/\/doi.org\/10.1086\/379048","journal-title":"J Infect Dis"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1086\/528696","volume":"197","author":"MJ Levin","year":"2008","unstructured":"Levin MJ, Oxman MN, Zhang JH et al (2008) Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis 197:825\u2013835. https:\/\/doi.org\/10.1086\/528696","journal-title":"J Infect Dis"},{"key":"7_CR50","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1086\/510532","volume":"195","author":"VN Loparev","year":"2007","unstructured":"Loparev VN, Rubtcova E, Seward JF et al (2007) DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. J Infect Dis 195:502\u2013510. https:\/\/doi.org\/10.1086\/510532","journal-title":"J Infect Dis"},{"key":"7_CR51","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1056\/NEJM199009063231002","volume":"323","author":"R Mahalingam","year":"1990","unstructured":"Mahalingam R, Wellish M, Wolf W et al (1990) Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med 323:627\u2013631. https:\/\/doi.org\/10.1056\/NEJM199009063231002","journal-title":"N Engl J Med"},{"key":"7_CR52","first-page":"1","volume":"56","author":"M Marin","year":"2007","unstructured":"Marin M, G\u00fcris D, Chaves SS et al (2007) Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56:1\u201340","journal-title":"MMWR Recomm Rep"},{"key":"7_CR53","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1542\/peds.2008-0567","volume":"122","author":"M Marin","year":"2008","unstructured":"Marin M, Meissner HC, Seward JF (2008) Varicella prevention in the United States: a review of successes and challenges. Pediatrics 122:e744\u2013e751. https:\/\/doi.org\/10.1542\/peds.2008-0567","journal-title":"Pediatrics"},{"key":"7_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004885","volume":"11","author":"A Markus","year":"2015","unstructured":"Markus A, Lebenthal-Loinger I, Yang IH et al (2015) An in vitro model of latency and reactivation of Varicella Zoster Virus in human stem cell-derived neurons. PLoS Pathog 11:e1004885. https:\/\/doi.org\/10.1371\/journal.ppat.1004885","journal-title":"PLoS Pathog"},{"key":"7_CR55","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1128\/JVI.69.9.5236-5242.1995","volume":"69","author":"JF Moffat","year":"1995","unstructured":"Moffat JF, Stein MD, Kaneshima H, Arvin AM (1995) Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J Virol 69:5236\u20135242","journal-title":"J Virol"},{"key":"7_CR56","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/JVI.72.2.965-974.1998","volume":"72","author":"JF Moffat","year":"1998","unstructured":"Moffat JF, Zerboni L, Kinchington PR et al (1998) Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 72:965\u2013974","journal-title":"J Virol"},{"key":"7_CR57","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1212\/WNL.0b013e3182267bfa","volume":"77","author":"MA Nagel","year":"2011","unstructured":"Nagel MA, Traktinskiy I, Azarkh Y et al (2011) Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology 77:364\u2013370. https:\/\/doi.org\/10.1212\/WNL.0b013e3182267bfa","journal-title":"Neurology"},{"key":"7_CR58","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/jamaneurol.2015.2101","volume":"72","author":"MA Nagel","year":"2015","unstructured":"Nagel MA, White T, Khmeleva N et al (2015) Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for Giant cell arteritis. JAMA Neurol 72:1281\u20131287. https:\/\/doi.org\/10.1001\/jamaneurol.2015.2101","journal-title":"JAMA Neurol"},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"10203","DOI":"10.1128\/JVI.01331-12","volume":"86","author":"WJD Ouwendijk","year":"2012","unstructured":"Ouwendijk WJD, Choe A, Nagel MA et al (2012a) Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death. J Virol 86:10203\u201310206. https:\/\/doi.org\/10.1128\/JVI.01331-12","journal-title":"J Virol"},{"key":"7_CR60","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s13365-012-0095-0","volume":"18","author":"WJD Ouwendijk","year":"2012","unstructured":"Ouwendijk WJD, Flowerdew SE, Wick D et al (2012b) Immunohistochemical detection of intra-neuronal VZV proteins in snap-frozen human ganglia is confounded by antibodies directed against blood group A1-associated antigens. J Neurovirol 18:172\u2013180. https:\/\/doi.org\/10.1007\/s13365-012-0095-0","journal-title":"J Neurovirol"},{"key":"7_CR61","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR et al (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271\u20132284. https:\/\/doi.org\/10.1056\/NEJMoa051016","journal-title":"N Engl J Med"},{"key":"7_CR62","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1016\/j.vaccine.2016.04.059","volume":"34","author":"T Ozaki","year":"2016","unstructured":"Ozaki T, Asano Y (2016) Development of varicella vaccine in Japan and future prospects. Vaccine 34:3427\u20133433. https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.059","journal-title":"Vaccine"},{"key":"7_CR63","first-page":"69","volume":"21","author":"T Ozaki","year":"1978","unstructured":"Ozaki T, Nagayoshi S, Morishima T et al (1978) Use of a live varicella vaccine for acute leukemic children shortly after exposure in a children\u2019s ward. Biken J 21:69\u201372","journal-title":"Biken J"},{"key":"7_CR64","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1056\/NEJM199403313301305","volume":"330","author":"AL Pastuszak","year":"1994","unstructured":"Pastuszak AL, Levy M, Schick B et al (1994) Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 330:901\u2013905. https:\/\/doi.org\/10.1056\/NEJM199403313301305","journal-title":"N Engl J Med"},{"key":"7_CR65","doi-asserted-by":"publisher","first-page":"10695","DOI":"10.1128\/JVI.01067-12","volume":"86","author":"GA Peters","year":"2012","unstructured":"Peters GA, Tyler SD, Carpenter JE et al (2012) The attenuated genotype of Varicella-Zoster Virus includes an ORF0 transitional stop codon mutation. J Virol 86:10695\u201310703. https:\/\/doi.org\/10.1128\/JVI.01067-12","journal-title":"J Virol"},{"key":"7_CR66","doi-asserted-by":"publisher","first-page":"332ra46","DOI":"10.1126\/scitranslmed.aaf1725","volume":"8","author":"Q Qi","year":"2016","unstructured":"Qi Q, Cavanagh MM, Le Saux S et al (2016a) Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination. Sci Transl Med 8:332ra46. https:\/\/doi.org\/10.1126\/scitranslmed.aaf1725","journal-title":"Sci Transl Med"},{"key":"7_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005892","volume":"12","author":"Q Qi","year":"2016","unstructured":"Qi Q, Cavanagh MM, Le Saux S et al (2016b) Defective T memory cell differentiation after Varicella Zoster vaccination in older individuals. PLoS Pathog 12:e1005892. https:\/\/doi.org\/10.1371\/journal.ppat.1005892","journal-title":"PLoS Pathog"},{"key":"7_CR68","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1086\/423210","volume":"190","author":"ML Quinlivan","year":"2004","unstructured":"Quinlivan ML, Gershon AA, Steinberg SP, Breuer J (2004) Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus. J Infect Dis 190:793\u2013796. https:\/\/doi.org\/10.1086\/423210","journal-title":"J Infect Dis"},{"key":"7_CR69","doi-asserted-by":"publisher","first-page":"E2403","DOI":"10.1073\/pnas.1522575113","volume":"113","author":"T Sadaoka","year":"2016","unstructured":"Sadaoka T, Depledge DP, Rajbhandari L et al (2016) In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency. Proc Natl Acad Sci U S A 113:E2403\u2013E2412. https:\/\/doi.org\/10.1073\/pnas.1522575113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR70","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/infdis\/jiq052","volume":"203","author":"ED Shapiro","year":"2011","unstructured":"Shapiro ED, Vazquez M, Esposito D et al (2011) Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis 203:312\u2013315. https:\/\/doi.org\/10.1093\/infdis\/jiq052","journal-title":"J Infect Dis"},{"key":"7_CR71","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","volume":"2","author":"M Takahashi","year":"1974","unstructured":"Takahashi M, Otsuka T, Okuno Y et al (1974) Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2:1288\u20131290","journal-title":"Lancet"},{"key":"7_CR72","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1442-200X.1997.tb03664.x","volume":"39","author":"N Takayama","year":"1997","unstructured":"Takayama N, Minamitani M, Takayama M (1997) High incidence of breakthrough varicella observed in healthy Japanese children immunized with live attenuated varicella vaccine (Oka strain). Acta Paediatr Jpn 39:663\u2013668","journal-title":"Acta Paediatr Jpn"},{"key":"7_CR73","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1128\/CVI.05021-11","volume":"18","author":"S Thiele","year":"2011","unstructured":"Thiele S, Borschewski A, K\u00fcchler J et\u00a0al (2011) Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions. Clin Vaccine Immunol 18:1058\u20131066. https:\/\/doi.org\/10.1128\/CVI.05021-11","journal-title":"Clin Vaccine Immunol"},{"key":"7_CR74","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.vaccine.2007.12.038","volume":"26","author":"P Vandepapeli\u00e8re","year":"2008","unstructured":"Vandepapeli\u00e8re P, Horsmans Y, Moris P et al (2008) Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. Vaccine 26:1375\u20131386. https:\/\/doi.org\/10.1016\/j.vaccine.2007.12.038","journal-title":"Vaccine"},{"key":"7_CR75","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.1128\/JVI.02690-09","volume":"84","author":"JG Victoria","year":"2010","unstructured":"Victoria JG, Wang C, Jones MS et al (2010) Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J Virol 84:6033\u20136040. https:\/\/doi.org\/10.1128\/JVI.02690-09","journal-title":"J Virol"},{"key":"7_CR76","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/infdis\/jit405","volume":"208","author":"S Weinmann","year":"2013","unstructured":"Weinmann S, Chun C, Schmid DS et al (2013) Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005\u20132009. J Infect Dis 208:1859\u20131868. https:\/\/doi.org\/10.1093\/infdis\/jit405","journal-title":"J Infect Dis"},{"key":"7_CR77","unstructured":"WHO experts committee on biological standardization (1994) Requirements for varicella vaccine (live)"},{"key":"7_CR78","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1016\/j.vaccine.2016.08.044","volume":"34","author":"T Yoshikawa","year":"2016","unstructured":"Yoshikawa T, Ando Y, Nakagawa T, Gomi Y (2016) Safety profile of the varicella vaccine (Oka vaccine strain) based on reported cases from 2005 to 2015 in Japan. Vaccine 34:4943\u20134947. https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.044","journal-title":"Vaccine"},{"key":"7_CR79","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.virol.2004.10.047","volume":"332","author":"L Zerboni","year":"2005","unstructured":"Zerboni L, Hinchliffe S, Sommer MH et al (2005a) Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka\/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model. Virology 332:337\u2013346. https:\/\/doi.org\/10.1016\/j.virol.2004.10.047","journal-title":"Virology"},{"key":"7_CR80","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1073\/pnas.0501045102","volume":"102","author":"L Zerboni","year":"2005","unstructured":"Zerboni L, Ku C-C, Jones CD et al (2005b) Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc Natl Acad Sci U S A 102:6490\u20136495. https:\/\/doi.org\/10.1073\/pnas.0501045102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR81","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1128\/JVI.05950-11","volume":"86","author":"L Zerboni","year":"2012","unstructured":"Zerboni L, Sobel RA, Lai M et al (2012) Apparent expression of varicella-zoster virus proteins in latency resulting from reactivity of murine and rabbit antibodies with human blood group a determinants in sensory neurons. J Virol 86:578\u2013583. https:\/\/doi.org\/10.1128\/JVI.05950-11","journal-title":"J Virol"},{"key":"7_CR82","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrmicro3215","volume":"12","author":"L Zerboni","year":"2014","unstructured":"Zerboni L, Sen N, Oliver SL, Arvin AM (2014) Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol 12:197\u2013210. https:\/\/doi.org\/10.1038\/nrmicro3215","journal-title":"Nat Rev Microbiol"}],"container-title":["Advances in Experimental Medicine and Biology","Human Herpesviruses"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-7230-7_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T04:20:31Z","timestamp":1693714831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-7230-7_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9789811072291","9789811072307"],"references-count":82,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-7230-7_7","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}